Paul Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Paul Lee has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Jerry R. Greenfield
Department of Endocrinology, St Vincent's Hospital, Sydney, NSW, Australia
6 shared publications- Jacqueline R. Center
Garvan Institute of Medical Research, Sydney, Australia
5 shared publications Lesley V. Campbell
5 shared publicationsJ. R. Greenfield
Department of Endocrinology
3 shared publications- Jerry Richard Greenfield
Translational Diabetes Research Laboratory Victor Chang Cardiac Research Institute Sydney Australia
3 shared publications John A. Eisman
3 shared publications
Latest Publications
- 15 December 2016
- Published by Wiley in Clinical Endocrinology
- Vol. 86 (3) , 309-314
Preoperative alpha-blockade in phaeochromocytoma and paraganglioma: is it always necessary?
Resection of phaeochromocytoma and paraganglioma (PPGL) is traditionally preceded by alpha-blockade to prevent complications of haemodynamic instability intraoperatively. While there is general agreement on preoperative alpha-blockade for classic PPGLs presenting with hypertension, it is less clear whether alpha-blockade is necessary in predominantly dopamine-secreting tumours, normotensive PPGLs, as well as tumours that appear to be biochemically “silent”. Preoperative management of these “atypical” PPGLs is challenging and the treatment approach must be individualised, carefully weighing the risk of intraoperative hypertension against the possibility of orthostatic and prolonged postoperative hypotension. Consideration of anti-hypertensive medication pharmacology in light of catecholamine physiology and PPGL secretory profile will facilitate the formulation of individualised preoperative preparatory strategies.
- 15 December 2016
- Published by Wiley in Clinical Endocrinology
- Vol. 86 (3) , 309-314
Preoperative alpha-blockade in phaeochromocytoma and paraganglioma: is it always necessary?
Resection of phaeochromocytoma and paraganglioma (PPGL) is traditionally preceded by alpha-blockade to prevent complications of haemodynamic instability intraoperatively. While there is general agreement on preoperative alpha-blockade for classic PPGLs presenting with hypertension, it is less clear whether alpha-blockade is necessary in predominantly dopamine-secreting tumours, normotensive PPGLs, as well as tumours that appear to be biochemically “silent”. Preoperative management of these “atypical” PPGLs is challenging and the treatment approach must be individualised, carefully weighing the risk of intraoperative hypertension against the possibility of orthostatic and prolonged postoperative hypotension. Consideration of anti-hypertensive medication pharmacology in light of catecholamine physiology and PPGL secretory profile will facilitate the formulation of individualised preoperative preparatory strategies.
- 1 December 2016
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 311 (6) , E950-E951
Quenching the thirst for hunger
Maintenance of energy and water balance is fundamental to survival across organisms. A recent study reveals a unique neuroendocrine node in Drosophila that simultaneously surveys systemic caloric and osmotic fluctuations to fine-tune food and water consumption, shedding new neuronal mechanistic insight on anti-diabetes therapeutics with dual glucose/osmolality modulatory actions.
- 1 December 2016
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 311 (6) , E950-E951
Quenching the thirst for hunger
Maintenance of energy and water balance is fundamental to survival across organisms. A recent study reveals a unique neuroendocrine node in Drosophila that simultaneously surveys systemic caloric and osmotic fluctuations to fine-tune food and water consumption, shedding new neuronal mechanistic insight on anti-diabetes therapeutics with dual glucose/osmolality modulatory actions.
- 1 April 2016
- Published by Elsevier in Cell Metabolism
- Vol. 23 (4) , 602-609
Brown Adipose Tissue Exhibits a Glucose-Responsive Thermogenic Biorhythm in Humans
- 1 April 2016
- Published by Elsevier in Cell Metabolism
- Vol. 23 (4) , 602-609
Brown Adipose Tissue Exhibits a Glucose-Responsive Thermogenic Biorhythm in Humans
- 1 December 2015
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 418, 184-190
Non-pharmacological and pharmacological strategies of brown adipose tissue recruitment in humans
- 1 December 2015
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 418, 184-190
Non-pharmacological and pharmacological strategies of brown adipose tissue recruitment in humans
- 1 June 2015
- Published by Elsevier in Cell Metabolism
- Vol. 21 (6) , 795-796
The Sum of All Browning in FGF21 Therapeutics
- 1 June 2015
- Published by Elsevier in Cell Metabolism
- Vol. 21 (6) , 795-796
The Sum of All Browning in FGF21 Therapeutics
- 1 April 2015
- Published by Wiley in Clinical Endocrinology
- Vol. 83 (5) , 748-749
‘Hyperaldosteronaemic or normocalcaemic’ hyperparathyroidism?
- 1 April 2015
- Published by Wiley in Clinical Endocrinology
- Vol. 83 (5) , 748-749
‘Hyperaldosteronaemic or normocalcaemic’ hyperparathyroidism?
- 16 February 2015
- Published by Wiley in Clinical Endocrinology
- Vol. 83 (2) , 157-161
What is the optimal bone‐preserving strategy for patients with Addison's disease?
Addison's disease is associated with low bone mineral density and increased risk of hip fractures. Causes are multifactorial, contributed by underlying adrenocortical hormonal deficiency, associated autoimmune endocrinopathies, electrolyte disturbances and, in some patients, supraphysiologic glucocorticoid replacement. Recent realization of physiologic cortisol production rate has revised downwards glucocorticoid replacement dosages. Meanwhile, new research has emerged suggesting complex interplay between sodium and calcium homoeostasis under the influence of mineralocorticoid and parathyroid hormone that may impact bone health. As the prevalence of Addison's disease is rising, and osteoporosis and fractures are associated with significant morbidity and increased mortality, attention to bone preservation in Addison's disease is of clinical relevance and importance. We suggest an approach to bone health in Addison's disease integrating physiologic adrenocortical hormonal replacement with electrolyte and mineral homoeostasis optimization.
- 16 February 2015
- Published by Wiley in Clinical Endocrinology
- Vol. 83 (2) , 157-161
What is the optimal bone‐preserving strategy for patients with Addison's disease?
Addison's disease is associated with low bone mineral density and increased risk of hip fractures. Causes are multifactorial, contributed by underlying adrenocortical hormonal deficiency, associated autoimmune endocrinopathies, electrolyte disturbances and, in some patients, supraphysiologic glucocorticoid replacement. Recent realization of physiologic cortisol production rate has revised downwards glucocorticoid replacement dosages. Meanwhile, new research has emerged suggesting complex interplay between sodium and calcium homoeostasis under the influence of mineralocorticoid and parathyroid hormone that may impact bone health. As the prevalence of Addison's disease is rising, and osteoporosis and fractures are associated with significant morbidity and increased mortality, attention to bone preservation in Addison's disease is of clinical relevance and importance. We suggest an approach to bone health in Addison's disease integrating physiologic adrenocortical hormonal replacement with electrolyte and mineral homoeostasis optimization.
- Open Access
- 13 October 2014
- Published by American Diabetes Association in Diabetes
- Vol. 63 (11) , 3593-3595
PTH-Vitamin D-Glycemia Interactions Reloaded
Traditionally viewed as a key regulator of musculoskeletal health, recent studies also have pointed to pleiotropic roles of vitamin D in the modulation of metabolic and vascular functions (1). Hypovitaminosis D is associated with obesity (2), and low vitamin D states predict higher fasting glycemia and insulin resistance in population studies (3,4), yet other studies showed no relations between vitamin D status and glucose homeostasis after adjusting for adiposity (5,6). Vitamin D supplementation has not consistently benefited glycemia in intervention trials despite adequate increments into a “normal range” (7). The debate surrounding vitamin D and glucose metabolism continues. Aside from assay variability, subject population, and lifestyle confounders that could complicate data interpretation, a fundamental unanswered question is what constitutes vitamin D sufficiency. Hormonal axes are classically evaluated on multiple levels, encompassing negative feedback and positive stimulation. The vitamin D hormonal system is chiefly under the regulation of the parathyroid hormone (PTH), which stimulates the conversion of circulating 25-hydroxyvitamin D (25-OH-D) to its active form, 1,25-dihydroxyvitamin D (1,25-(OH)2D). While best known to occur in the kidneys, local tissue 1α-hydroxylase expression enables active vitamin D synthesis in a paracrine fashion (1). The interactions between endocrine and paracrine vitamin D systems are not well understood and may underscore the apparent dissociation between …
- 13 October 2014
- Published by American Diabetes Association in Diabetes
- Vol. 63 (11) , 3593-3595
Open AccessPTH-Vitamin D-Glycemia Interactions Reloaded
Traditionally viewed as a key regulator of musculoskeletal health, recent studies also have pointed to pleiotropic roles of vitamin D in the modulation of metabolic and vascular functions (1). Hypovitaminosis D is associated with obesity (2), and low vitamin D states predict higher fasting glycemia and insulin resistance in population studies (3,4), yet other studies showed no relations between vitamin D status and glucose homeostasis after adjusting for adiposity (5,6). Vitamin D supplementation has not consistently benefited glycemia in intervention trials despite adequate increments into a “normal range” (7). The debate surrounding vitamin D and glucose metabolism continues. Aside from assay variability, subject population, and lifestyle confounders that could complicate data interpretation, a fundamental unanswered question is what constitutes vitamin D sufficiency. Hormonal axes are classically evaluated on multiple levels, encompassing negative feedback and positive stimulation. The vitamin D hormonal system is chiefly under the regulation of the parathyroid hormone (PTH), which stimulates the conversion of circulating 25-hydroxyvitamin D (25-OH-D) to its active form, 1,25-dihydroxyvitamin D (1,25-(OH)2D). While best known to occur in the kidneys, local tissue 1α-hydroxylase expression enables active vitamin D synthesis in a paracrine fashion (1). The interactions between endocrine and paracrine vitamin D systems are not well understood and may underscore the apparent dissociation between …
- 22 February 2012
- Published by Wiley in Internal Medicine Journal
- Vol. 42 (2) , 198-202
Recreational drug use in type 1 diabetes: an invisible accomplice to poor glycaemic control?
Recreational drug use during ‘rave’ parties is increasingly popular, but the impact of recreational drug use in type 1 diabetes (T1D) is not known. We determined the self‐reported pattern and effects of recreational/illicit drug use in Australians with T1D people by inviting people with T1D to participate in an anonymous online/paper survey of drug use, through national radio broadcast and online/hospital advertising. Of the people with T1D who responded to our survey, more than three quarters reported having used recreational/illicit drug, but few people had informed health professionals about drug use. Drug use was associated with worse glycaemic control and higher risk of diabetic ketoacidosis. Medical awareness of common, currently underreported, drug use in young people with T1D is essential. It offers the possibility of helping such patients improve related suboptimal metabolic control.
- 22 February 2012
- Published by Wiley in Internal Medicine Journal
- Vol. 42 (2) , 198-202
Recreational drug use in type 1 diabetes: an invisible accomplice to poor glycaemic control?
Recreational drug use during ‘rave’ parties is increasingly popular, but the impact of recreational drug use in type 1 diabetes (T1D) is not known. We determined the self‐reported pattern and effects of recreational/illicit drug use in Australians with T1D people by inviting people with T1D to participate in an anonymous online/paper survey of drug use, through national radio broadcast and online/hospital advertising. Of the people with T1D who responded to our survey, more than three quarters reported having used recreational/illicit drug, but few people had informed health professionals about drug use. Drug use was associated with worse glycaemic control and higher risk of diabetic ketoacidosis. Medical awareness of common, currently underreported, drug use in young people with T1D is essential. It offers the possibility of helping such patients improve related suboptimal metabolic control.
- Open Access
- 1 January 2011
- Published by Springer Nature in Critical Care
- Vol. 15 (2) , 154-2
How deficient are vitamin D deficient critically ill patients?
- 1 January 2011
- Published by Springer Nature in Critical Care
- Vol. 15 (2) , 154-2
Open AccessHow deficient are vitamin D deficient critically ill patients?